BE876263A - Procede therapeutique pour traiter les patients uremiques et composition liquide de dialyse pour la mise en oeuvre de ce procede - Google Patents

Procede therapeutique pour traiter les patients uremiques et composition liquide de dialyse pour la mise en oeuvre de ce procede

Info

Publication number
BE876263A
BE876263A BE0/195171A BE195171A BE876263A BE 876263 A BE876263 A BE 876263A BE 0/195171 A BE0/195171 A BE 0/195171A BE 195171 A BE195171 A BE 195171A BE 876263 A BE876263 A BE 876263A
Authority
BE
Belgium
Prior art keywords
uemic
patients
treating
implementation
liquid dialysis
Prior art date
Application number
BE0/195171A
Other languages
English (en)
French (fr)
Inventor
S Tau
Original Assignee
Cavazza Claudio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cavazza Claudio filed Critical Cavazza Claudio
Publication of BE876263A publication Critical patent/BE876263A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
BE0/195171A 1978-05-15 1979-05-15 Procede therapeutique pour traiter les patients uremiques et composition liquide de dialyse pour la mise en oeuvre de ce procede BE876263A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49355/78A IT1156741B (it) 1978-05-15 1978-05-15 Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi

Publications (1)

Publication Number Publication Date
BE876263A true BE876263A (fr) 1979-09-03

Family

ID=11270450

Family Applications (2)

Application Number Title Priority Date Filing Date
BE0/195171A BE876263A (fr) 1978-05-15 1979-05-15 Procede therapeutique pour traiter les patients uremiques et composition liquide de dialyse pour la mise en oeuvre de ce procede
BE0/195170A BE876262A (fr) 1978-05-15 1979-05-15 Procede de preparation de l'acide (s,5s)- -amino-3-chloro-isoxazoline-5-acetique, nouveaux analogues de cet acide, et preparation de ces analogues

Family Applications After (1)

Application Number Title Priority Date Filing Date
BE0/195170A BE876262A (fr) 1978-05-15 1979-05-15 Procede de preparation de l'acide (s,5s)- -amino-3-chloro-isoxazoline-5-acetique, nouveaux analogues de cet acide, et preparation de ces analogues

Country Status (14)

Country Link
US (2) US4272549A (xx)
JP (2) JPS54151130A (xx)
BE (2) BE876263A (xx)
CA (2) CA1134274A (xx)
CH (2) CH642550A5 (xx)
DE (2) DE2919543A1 (xx)
DK (2) DK198179A (xx)
FR (2) FR2425854A1 (xx)
GB (2) GB2020550B (xx)
IE (2) IE48122B1 (xx)
IL (2) IL57265A0 (xx)
IT (1) IT1156741B (xx)
LU (2) LU81263A1 (xx)
NL (2) NL7903823A (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
DE2921852A1 (de) * 1979-05-29 1980-12-11 Fresenius Chem Pharm Ind Lipide senkendes mittel
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
JPS5661314A (en) * 1979-10-24 1981-05-26 Otsuka Pharmaceut Factory Inc Preventive against side-effect for dialytic patient
US4335335A (en) * 1980-02-11 1982-06-15 Rca Corporation Television receiver high voltage protection circuit
IT1145362B (it) * 1980-03-06 1986-11-05 Sigma Tau Ind Farmaceuti Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
DE3224823A1 (de) * 1982-07-02 1984-01-05 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer fuer den entsprechenden krankheitsfall optimierten elektrolytloesung zur anwendung in der haemodialyse
US4687808A (en) * 1982-08-12 1987-08-18 Biospecific Technologies, Inc. Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
US5719119A (en) * 1985-12-18 1998-02-17 British Technology Group, Ltd. Parenteral nutrition therapy with amino acids
DE3821043A1 (de) * 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
JP5033276B2 (ja) 1997-05-05 2012-09-26 ストライカー コーポレイション 急性腎不全の治療
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS
KR100461572B1 (ko) * 1999-03-27 2004-12-14 삼성정밀화학 주식회사 Ｌ-카르니틴 칼슘 염과 이의 제조방법
BE1012930A3 (fr) * 1999-10-08 2001-06-05 Lhoist Rech & Dev Sa Produit a base d'oxyde de calcium et son procede de fabrication.
MXPA02003635A (es) * 1999-10-11 2002-10-23 Sigma Tau Ind Farmaceuti Uso de l-carnitina y sus derivados de alcanoilo como agentes osmoticos en soluciones para uso medico.
US6335369B1 (en) * 2000-01-19 2002-01-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
US6914076B2 (en) * 2000-01-19 2005-07-05 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
WO2001052836A1 (en) * 2000-01-19 2001-07-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Intravenous carnitine for the treatment of chronic uraemic patients undergoing periodical dialysis
US6429230B1 (en) 2000-01-19 2002-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液
US20070087975A1 (en) * 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
GR1009311B (el) * 2017-01-26 2018-06-19 Βερμα Ντραγκς - Verma Drugs Abee Οξινο κιτρικο διαλυμα αιμοκαθαρσης με l-καρνιτινη

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822344A (en) * 1967-04-28 1974-07-02 Cox & Co Ltd A Pharmaceutical compositions providing potassium chloride in aqueous solution
ES356006A1 (es) * 1967-07-03 1969-12-16 Italseber Sa Procedimiento para la preparacion de clorhidrato de acetoa-cetilcarnitina dextrogira y levogira.
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
JPS5058213A (xx) * 1973-09-26 1975-05-21
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
JPS53124610A (en) * 1977-05-17 1978-10-31 Sodekusu:Kk Dialysate
JPS5428809A (en) * 1977-08-08 1979-03-03 Medekusu Kk Injection solution for filter type artificial kidney
IT1143611B (it) * 1977-11-03 1986-10-22 Sigma Tau Ind Farmaceuti Applicazione della acetil-carnitina nella terapia delle affezioni cardiache di/tipo anossico,ischemico,cardiotossico e nelle sindromi aritmiche
FR2414914A1 (fr) * 1978-01-18 1979-08-17 Sigma Tau Ind Farmaceuti Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi

Also Published As

Publication number Publication date
IL57265A0 (en) 1979-09-30
BE876262A (fr) 1979-09-03
NL7903823A (nl) 1979-11-19
CH642549A5 (it) 1984-04-30
FR2425854B1 (xx) 1983-08-05
IT1156741B (it) 1987-02-04
FR2425855B1 (xx) 1983-09-16
IE790951L (en) 1979-11-15
IT7849355A0 (it) 1978-05-15
DE2919593A1 (de) 1979-11-22
DE2919593C2 (xx) 1990-12-06
FR2425854A1 (fr) 1979-12-14
GB2020550A (en) 1979-11-21
LU81264A1 (fr) 1979-09-10
US4237167A (en) 1980-12-02
NL7903824A (nl) 1979-11-19
GB2020550B (en) 1982-12-15
JPS54151130A (en) 1979-11-28
GB2020552B (en) 1982-10-20
LU81263A1 (fr) 1979-09-10
US4272549A (en) 1981-06-09
JPH0530809B2 (xx) 1993-05-11
IE48122B1 (en) 1984-10-03
CA1135626A (en) 1982-11-16
JPS54151131A (en) 1979-11-28
DK198179A (da) 1979-11-16
FR2425855A1 (fr) 1979-12-14
DK198279A (da) 1979-11-16
IE790952L (en) 1979-11-15
CH642550A5 (it) 1984-04-30
IL57267A0 (en) 1979-09-30
CA1134274A (en) 1982-10-26
DE2919543A1 (de) 1979-11-22
GB2020552A (en) 1979-11-21
IE48121B1 (en) 1984-10-03

Similar Documents

Publication Publication Date Title
BE876263A (fr) Procede therapeutique pour traiter les patients uremiques et composition liquide de dialyse pour la mise en oeuvre de ce procede
FR2520236B1 (fr) Procede et appareil pour la mise en oeuvre d'une therapie intraveineuse comprenant une hyperalimentation
BE877837A (fr) Procede et appareil de preparation de dialysat pour hemodialyse
FR2517972B1 (fr) Procede et appareil pour l'irradiation de fluides
DE3162578D1 (en) Process for heat treatment of aqueous solution containing human blood coagulation factor xiii
FR2619923B1 (fr) Procede et appareil pour controler les composants sanguins
FR2530953B1 (fr) Emulsion perfluoro-chimique utilisable comme sang artificiel et procede pour sa preparation
BE889524A (fr) Appareil et procede pour le melange externe controle de substances
FR2511668B1 (fr) Procede et composition pour le traitement de systemes aqueux
LU80972A1 (fr) Composition de dialyse et procede d'enlevement des substances uremiques dans un rein artificiel
FR2565493B1 (fr) Appareil d'electrotherapie, pour le traitement du cuir chevelu
FR2525099B1 (fr) Procede d'application d'une electrode sur la peau d'un patient et liquide pour la mise en oeuvre de ce procede
EP0117064A3 (en) Process for heat treatment of blood coagulation factor viii
JPS57159538A (en) Ultrasonic device particularly related to treatment of liquid
FR2282637A1 (fr) Procede pour rendre visibles les defauts des surfaces et appareil pour l'application de ce procede
JPS5227886A (en) Method of continuous liquid treatment of ropeeshaped fiber material
FR2316989A1 (fr) Procede et appareillage pour la preparation continue de cristaux
JPS57188261A (en) Method and apparatus for producing blood dialyzing liquid
FR2599592B1 (fr) Composition liquide pour le traitement preventif et curatif des maladies cryptogamiques de type oidium et procede pour la mise en oeuvre de cette composition
FR2540877B1 (fr) Appareil et procede pour la preparation de solutions de polymere
FR2553440B1 (fr) Procede et appareil pour le retrecissement par compression d'un tissu
BE879015A (fr) Methode et appareillage pour la circonvolution de surfaces continues
FR2336947A1 (fr) Procede et appareil pour la detoxication du sang, d'un liquide de dialysat et de liquides analogues
BE810006A (fr) Procede et appareil pour le traitement continu d'un tissu en mouvement
JPS57206452A (en) Pasturization of body liquid treating apparatus

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CAVAZZA CLAUDIO

Effective date: 19970531